Innovo Therapeutics Inc. has announced promising results from its Phase 2 clinical trial for INV-001, an innovative treatment for post-thyroidectomy scars. The trial, conducted across four hospitals in Korea, including…
As the youth mental health crisis worsens, Akron Children’s is preparing to introduce a new tool to help teenagers manage anxiety and depression more effectively. Akron Children’s has partnered with…
Weave (NYSE: WEAV), a top all-in-one customer experience and payments platform, has clinched its fourth consecutive Dental Product Shopper Readers’ Choice Award for both Patient Communication and Dental Analytics software.…
HistoSonics has closed an oversubscribed $102 million Series D financing round, led by Alpha Wave Ventures. New investors Amzak Health and HealthQuest Capital joined existing backers Johnson & Johnson Innovation…
Ontrak, Inc. (NASDAQ: OTRK), a top AI-driven and telehealth-enabled behavioral healthcare company, has earned HITRUST Risk-based, 2-year (r2) certification for the customer data exchange components of its Ontrak Advanced Engagement…
Francisco Partners, a global investment firm specializing in technology and healthcare, has announced the sale of QGenda to Hearst. Financial terms of the deal were not disclosed. QGenda, a leader…
UptimeHealth, a leader in healthcare technology solutions, is excited to announce a new partnership with Darby Dental Supply, a major dental distributor in the U.S. This collaboration represents a major…
CharmHealth, a top provider of healthcare technology solutions, has introduced its inaugural internship program designed to cultivate the next generation of healthtech leaders. This paid internship offers participants hands-on experience…
Insulet Corporation (NASDAQ: PODD), a global leader in tubeless insulin pump technology with its Omnipod® products, today announced its financial results for the quarter ending June 30, 2024. Second Quarter…
Ontrak, Inc. (NASDAQ: OTRK), a leader in AI-powered and technology-driven behavioral healthcare, today released its expected financial results for the second quarter ending June 30, 2024. These results are pending…
Hims & Hers Health, Inc. (NYSE: HIMS), a leading health and wellness platform, has released its financial results for the second quarter ended June 30, 2024. The details are available…
Eyedaptic, a leader in vision-enhancement technology, has introduced the EYE6 with Ivy, an advanced wearable vision aid featuring an AI-powered visual assistant. This next-generation smart glasses product is designed to…
